LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Disposable Device Developed for Infectious Diseases

By LabMedica International staff writers
Posted on 22 Aug 2013
An easy-to-use device that can detect a wide range of diseases in less than an hour based on color-changing paper is under development.

An instrument-free, paper-based, fully disposable device is being created for use in remote areas where access to medical diagnostic equipment is limited.

Image: Field-based Diagnostic Device (Photo courtesy of the University of Washington).
Image: Field-based Diagnostic Device (Photo courtesy of the University of Washington).

Scientists from the University of Washington (Seattle, WA, USA) have teamed up with those from General Electric Global Research (GE; Niskayuna, NY, USA) to develop the device. The medical instument will be about the size of a pack of playing cards, and can detect infectious disease by way of a simple nasal swab, in less than an hour. As part of this program, GE scientists will be developing next-generation paper and membrane materials, while also utilizing a suite of commercial papers and membranes, including Whatman Nucleic Acid and Protein Sample Preparation FTA cards (Piscataway, NJ, USA).

The first disease the scientists will target is methicillin-resistant Staphylococcus aureus (MRSA), a drug-resistant bacterium responsible for hard-to treat infections. MRSA is especially problematic in institutional settings, like hospitals prisons, and military bases, where people generally live in close quarters. Fast diagnosis is the key because MRSA infections can worsen rapidly, and in less than a week, take hold in human tissue and become very difficult to treat.

David Moore, PhD, the manager of the Membrane and Separation Technologies Laboratory, at GE Global Research, said, “The team is excited about this effort and the difference it could make. There's a strong desire to see the technology commercialized and used at clinics, hospitals, and the military health system, and eventually in the field and at home. We live in an on-demand world, where news and information is instantaneous. We've asked why the same can't be done for diagnosing infectious diseases where early detection is so critical to positive patient outcomes.”

Related Links:
University of Washington
General Electric Global Research
Whatman


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
New
Clinical Informatics Platform
CLARION™
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter

Latest Technology News

Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
22 Aug 2013  |   Technology

Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
22 Aug 2013  |   Technology

Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
22 Aug 2013  |   Technology



ADLM